Medicare Advantage enrollment down ~1.1M but margin above 3%
UnitedHealth Group reported strong Q2 2026 results, driven by better-than-expected performance in Medicare Advantage and OptumHealth, and raised full-year EPS guidance. The company remains cautious on elevated medical cost trends, especially in commercial lines, and is investing heavily in AI and operational improvements to drive long-term efficiency. Q2 adjusted EPS of $6.38 beat prior year's $4.08, with revenue of $112 billion.
Buzzberg readMedicare Advantage enrollment down ~1.1M but margin above 3%UnitedHealth Group reported strong Q2 2026 results, driven by better-than-expected performance in Medicare Advantage and OptumHealth, and raised full-year EPS guidance. The company remains cautious on elevated medical cost trends, especially in commercial lines, and is investing heavily in AI and operational improvements to drive long-term efficiency. Q2 adjusted EPS of $6.38 beat prior year's $4.08, with revenue of $112 billion.Read full analysisCollapse analysis
UnitedHealth Group reported strong Q2 2026 results, driven by better-than-expected performance in Medicare Advantage and OptumHealth, and raised full-year EPS guidance. The company remains cautious on elevated medical cost trends, especially in commercial lines, and is investing heavily in AI and operational improvements to drive long-term efficiency. Q2 adjusted EPS of $6.38 beat prior year's $4.08, with revenue of $112 billion.
Raised FY2026 adjusted EPS guidance to $19.50-$20.00.
Medicare Advantage margins expected to exceed 3% for the full year, with enrollment declining by ~1.1 million.
Commercial medical cost trends remain stubbornly high at >11%, delaying margin recovery past 2027.
Revenue$112.032B
+0% QoQ
EPS$6.38
-8% QoQ
Gross margin32.74%
reported
Op margin7.13%
reported
What changed this quarter
01
Margins
Medicare Advantage enrollment down ~1.1M but margin above 3%
Reported gross margin was 32.74%, reinforcing the quarter's better-than-guided profitability.
Reported gross margin was 32.74%, reinforcing the quarter's better-than-guided profitability.
03
Capital Return
Share repurchases raised to at least $5B from $2.5B
Raised FY2026 adjusted EPS guidance to $19.50-$20.00.
04
AI
Ambient AI documentation adopted by 70% of Optum providers
Management framed AI as an enterprise-wide accelerant, already improving service interactions, prior authorization, clinician documentation, and operational efficiency, and increasingly being commercialized into external products. They expect AI-driven gains to compound through…
AI, capex & demand read
AI
Platform & monetization
Management framed AI as an enterprise-wide accelerant, already improving service interactions, prior authorization, clinician documentation, and operational efficiency, and increasingly being commercialized into external products. They expect AI-driven gains to compound through 2027-2028 and position OptumInsight to help modernize the health system.
Demand
Bookings & conversion
Management raised full-year adjusted EPS guidance to $19.50-$20.00, citing durable earnings improvement across UnitedHealthcare and OptumHealth despite persistent elevated medical cost trends, particularly in commercial and Medicare segments.
Capex
Investment and capacity
No explicit capex figure was provided, but management signaled continued investment in AI, technology, care delivery, and customer experience, with the operating cost ratio expected at the higher end of the prior range. OptumInsight remains on a multi-year reinvestment and innovation path.
Tone · Confident
Management repeatedly cited momentum, better-than-expected execution, and confidence in durable long-term growth, while acknowledging persistent commercial cost pressure.
Supply-chain alpha
A1
Commercial medical cost trend is running above 11%, driven by exploitation of the No Surprises Act's independent dispute resolution (IDR) process by a concentrated group of providers, adding at least 100 basis points to total costs.
“First, the ineffective IDR process that's associated with the No Surprises Act is being exploited by select providers and select geographies. It's contributing 50 basis points or so of incremental trend in 2026, now totaling at least 100 b…”
OptumInsight's new AI-enabled digital prior authorization product (OptumReal) processed ~500,000 prior auths for external customers in its first quarter, saving 69,000 administrative hours.
“And year to date, it has, for external entities to UHG, processed about 69,000 prior auths, processed about half a million prior auths, and saved 69,000 administrative hours.”
Despite elevated overall medical costs, Medicare Advantage trend in 2026 is coming in below the initial 10% estimate, partly due to management's own initiatives like benefit design and network curation, not just lower utilization.
“However, it's also really important to highlight that while medical trends remain high versus the historical levels, the improvement we're seeing is also the result of targeted actions that we've taken and we've done that through benefit d…”